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Abstract
Background: Structured education programmes for individuals with Type 1 diabetes have become a recognised means
of delivering the knowledge and skills necessary for optimal self-management of the condition. The Dose Adjustment for
Normal Eating (DAFNE) programme has been shown to improve biomedical (HbA1c and rates of severe hypoglycaemia)
and psychosocial outcomes for up to 12 months following course delivery. The optimal way to support DAFNE graduates
and maintain the benefits of the programme has not been established. We aimed to compare 2 different methods of
follow-up of DAFNE graduates in a pragmatic clinical trial delivered in busy diabetes clinics on the island of Ireland.
Methods: Six participating centres were cluster randomised to deliver either group follow-up or a return to traditional
one-to-one clinic visits. In the intervention arm group follow-up was delivered at 6 and 12 months post DAFNE training
according to a curriculum developed for the study. In the control arm patients were seen individually in diabetes clinics
as part of routine care. Study outcomes included HbA1c levels, self-reported rates of severe hypoglycaemia, body weight
and measures of diabetes wellbeing and quality of life. These were measured at 6, 12 and 18 months after recruitment.
Generalisability (external validity) was maximised by recruiting study participants from existing DAFNE waiting lists in
each centre, by using broad inclusion criteria (including HbA1c values less than 13 percent with no lower limit) and by
using existing clinic staff to deliver the training and follow-up. Internal validity and treatment fidelity were maximised by
quality assuring the training of all DAFNE educators, by external peer review of the group follow-up sessions and by
striving for full attendance at follow-up visits. Assays of HbA1c were undertaken in a central laboratory.
Discussion: This pragmatic clinical trial evaluating group follow-up after a structured education programme has been
designed to have broad generalisability. The results should inform how best to manage the well educated patient with
Type 1 diabetes in the real world of clinical practice
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Background
Type 1 diabetes is a challenging condition to manage.
Once diagnosed it requires active patient involvement in
self-management of lifestyle issues including diet, physi-
cal activity and stress reduction. Most patients are
expected to self-administer insulin subcutaneously several
times a day and monitor its effects through frequent (and
painful) self-monitoring of capillary blood glucose levels.
Even in motivated patients it can be difficult to avoid day-
to-day fluctuations in blood glucose levels resulting in
symptomatic hyper- or hypoglycaemia. Although the risk
of chronic microvascular complications of diabetes can be
reduced by maintaining good glycaemic control, in an
individual patient there is no guarantee that their genetic
predisposition will not result in premature impairment of
vital organs including the eyes, kidneys and peripheral
nerves. Worry about complications and the fear of
hypoglycaemia are significant burdens for many people
living with the disease [1].
In Ireland and the UK systems for delivering care to indi-
viduals with type 1 diabetes have traditionally been very
hospital and healthcare professional oriented. Typically a
patient will be offered 3-4 visits per year to a hospital out-
patient clinic or Diabetes Centre. During these visits a
doctor and/or nurse will review certain clinical (e.g.,
weight, blood pressure) and laboratory (e.g., glycated hae-
moglobin, lipid levels) parameters and may establish tar-
gets for the patient to achieve. The patient's self-
monitoring of blood glucose data may be reviewed
although this does not always happen [2]. During at least
one of these visits annual screening for microvascular
complications will be undertaken. Traditionally, educa-
tion to support self-management has not been a major
focus of the diabetes clinic visit. If it is delivered the edu-
cation is often undertaken in an ad hoc manner and with-
out reference to a clear education plan. Perhaps not
surprisingly, when formally assessed through clinical
practice audit, outcomes associated with this traditional
method of diabetes care delivery are not good. This is true
both for adults and children with Type 1 diabetes [3,4]
where average levels of HbA1c of 8.6 to over 9.5 percent
have been reported.
The concept of therapeutic patient education was first
introduced to medical practice through the pioneering
work of Jean-Phillipe Assal, a Swiss doctor and education-
alist [5]. It aims to provide a more holistic approach to
patient care while ensuring that the knowledge, skills and
attitudes necessary to achieve effective self-management
(or mastery) of the long-term condition are delivered to
the patient. In the case of Type 1 diabetes a German dia-
betologist, Michael Berger, and his group in Düsseldorf
first operationalised this concept through the develop-
ment of an "Insulin Treatment and Teaching Programme"
in the late 1970's. They demonstrated through ran-
domised controlled trials that this approach was associ-
ated with improved glycaemic control and no increase in
rates of severe hypoglycaemia [6]. The approach is now
widespread throughout Germany [7]. In the late 1990's a
group of UK diabetes care professionals observed the Düs-
seldorf programme and adapted it for delivery in an out-
patient setting in 3 UK centres. The Dose Adjustment for
Normal Eating (or DAFNE) programme is a 5 day struc-
tured education programme covering all aspects of living
with diabetes with an emphasis on the key skill of estimat-
ing carbohydrate intake and matching insulin to food [8].
Using a waiting list controlled design among individuals
with poorly controlled diabetes the UK group showed sig-
nificant improvement in HbA1c levels at 6 months but a
diminution of this effect by 12 months. Rates of severe
hypoglycaemia did not increase with the improvement in
glycaemic control while patient-reported quality of life
improved significantly [9].
The DAFNE approach to diabetes care delivery was greeted
with considerable enthusiasm by patients [10], healthcare
professionals [11] and policy makers [12]. Since publica-
tion of the results of the DAFNE trial a further 74 diabetes
teams in the UK and Ireland have undertaken training of
their staff to deliver the programme [8]. Preliminary
reports of audit data from a number of these DAFNE cen-
tres suggest that improvements in glycaemic control and
psychosocial measures of wellbeing similar to the DAFNE
trial are being achieved in routine practice [13]. However,
unlike the situation in Germany where sustained benefit
has been reported [7], long-term data from the UK indi-
cate a diminution of the HbA1c improvement [14]. This
raises the issue of how best to support the long-term needs
of a patient who has been through DAFNE training. This
is the central question being addressed in the Irish DAFNE
Study. The hypothesis on which the study is based is that
group follow-up of DAFNE graduates is superior to indi-
vidual follow-up. The philosophy of the DAFNE pro-
gramme is grounded in Therapeutic Patient Education
Theory [15]. The group education approach incorporating
theories of adult learning has been used in structured edu-
cation programmes for people with Type 2 diabetes, such
as DESMOND [16] and ROMEO [17]. This paper
describes the design, setting, interventions and outcomes
of the Irish DAFNE Study, an 18 month cluster ran-
domised trial of self-management support among
patients with Type 1 diabetes.
Irish DAFNE Study Objectives
1. To develop a new model of ongoing care for DAFNE
graduates based on structured group follow-up and peer
supportTrials 2009, 10:88 http://www.trialsjournal.com/content/10/1/88
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2. To undertake an evaluation of this new model of care
(group follow-up of DAFNE graduates) comparing it with
"usual care", i.e., a return to the standard one-to-one clinic
visits following DAFNE training.
Methods
Design
The Irish DAFNE Study is a pragmatic, open, cluster ran-
domised, parallel group trial comparing 2 different meth-
ods of follow-up of patients with Type 1 diabetes who
have received the 5-day DAFNE programme in participat-
ing Irish hospitals. The study design and patient recruit-
ment are represented in Figure 1, using the CONSORT
flow diagram. The CONSORT approach will be followed
in reporting the results of this clinical trial [18].
Ethical approval was obtained from the Research Ethics
Committee of National University of Ireland, Galway (06/
Flow of centres and participants throughout the trial Figure 1
Flow of centres and participants throughout the trial.
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MAY/04), from the Research Ethics Committee of Galway
University Hospitals (CA 19), from COREC Northern Ire-
land (06/NIR01/126) and from the local research ethics
committee of each participating hospital. The decision to
obtain ethical approval from each participating centre was
based on the Irish legislature's interpretation of European
Union clinical trials legislation. Had the intervention
been a medicinal product (rather than an educational
package) this requirement would have been waived in
favour of approval from a single Research Ethics Commit-
tee.
Written informed consent was obtained from all partici-
pants in the Irish DAFNE Study after they had sufficient
time to consider the Patient Information Sheet and had
any questions relating to their participation answered by
study personnel.
Setting and Centre Recruitment
There are approximately 35 hospitals in the Republic of
Ireland delivering outpatient care to individuals with Type
1 diabetes. The equivalent number for Northern Ireland is
approximately 11 hospitals. In 2005 when this study was
conceptualised only 2 of these 46 hospitals was offering
the DAFNE programme to its patients. An additional 5
diabetes teams were in the process of receiving DAFNE
training or had plans to do so in the near future. One of
these centres was based in primary care and the lead doc-
tor declined an invitation to participate in the study. The
remaining 6 hospital-based teams agreed to combine their
efforts into delivering a programme of research, the Irish
DAFNE study. Although random selection of diabetes
centres would have been preferable this was not an option
because of the considerable commitment required on the
part of a diabetes team to become a DAFNE Centre (see
Figure 2).
Randomisation and Patient Recruitment
In the study we used a cluster randomisation with the unit
of randomisation being the participating DAFNE centre.
There are 6 participating centres in this study and it was
anticipated that each cluster would have approximately
75 participants each. We felt that DAFNE educators would
not be able to separate the 2 approaches to follow-up if
they were expected to deliver both. By randomising cen-
tres to deliver one or other method of follow-up we hoped
to minimise or avoid contamination between the two
arms of the study. The process of randomisation of centres
Becoming a DAFNE Centre Figure 2
Becoming a DAFNE Centre. DNS - Diabetes Nurse Specialist; DEP - DAFNE Educator Programme; DDP - DAFNE Doc-
tor Programme.
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was undertaken by a statistician not involved in the study
and who was blind to the identity of the hospitals being
randomised. The randomisation was done using a com-
puter-generated table of random numbers.
Prior to the study each of the participating DAFNE centres
used a similar approach to filling DAFNE courses. A wait-
ing list was maintained of individuals with Type 1 diabe-
tes attending the centre who had expressed an interest in
receiving DAFNE training. Using this list, groups of
approximately 50 patients were invited to attend a recruit-
ment evening in which the DAFNE course was described
and members of the DAFNE team were available to
answer questions. A brief description of the study aims
and objectives was included in the material presented at
the recruitment evening. Individuals were asked to con-
sider participating in the study but were not required to
give an answer at the recruitment evening. Following the
recruitment evening approximately 6 DAFNE courses
(each comprising 8 participants) would be filled. Prior to
the week of DAFNE training, individuals were invited to
attend a pre-course assessment visit. During this visit a
DAFNE educator would make sure that the individual met
the inclusion criteria for the study. Informed consent was
generally obtained at this visit and baseline study ques-
tionnaires were given to the patient.
Study Inclusion criteria:
1. At least 18 years of age at recruitment
2. Diagnosed with type 1 diabetes for at least one year
3. Attending the adult diabetes clinic in one of the partic-
ipating centres
4. The ability to speak and read English
5. A willingness to monitor blood sugar levels at regular
intervals
6. A willingness to transition to a basal/bolus insulin reg-
imen prior to DAFNE training (if not already on such a
regimen)
7. A glycosylated haemoglobin (HbA1c) level below 13
percent at recruitment.
Study Exclusion criteria:
1. Diagnosed with type 2 diabetes
2. Attending a paediatric clinic
3. Pregnant or planning a pregnancy in the next 2 years
4. The presence of advanced diabetes complications (e.g.
kidney failure with serum creatinine >250 μmol/L)
5. Serious co-morbidity likely to interfere with study par-
ticipation (assessed by the study centre's physician)
6. Previous DAFNE training or current use of a continuous
subcutaneous insulin infusion pump
DAFNE and Study Interventions
The DAFNE course is delivered over 5 consecutive days
and involves 38 hours of structured education in all
aspects of managing Type 1 diabetes. The education is
delivered by a Diabetes Specialist Nurse, Dietitian and
Doctor all of whom have undergone training in delivery
of the DAFNE curriculum. Figure 2 illustrates the rigorous
training process that a diabetes team has to go through to
become a DAFNE centre. One of the real strengths of the
DAFNE programme is the quality assurance that is incor-
porated into its delivery. DAFNE educators regularly
undergo peer review (both within their centre and via
external peer review) to ensure they are maintaining a
consistent high standard of course delivery. This means
that the basic package (the DAFNE course) delivered in
each of the participating DAFNE centres was uniform and
standardised to a level appropriate for a research study.
Details of the individual sessions that comprise the
DAFNE course are available on the DAFNE Collaborative
website [8] and all resource literature is available to
DAFNE graduates via the DAFNE Online website [19].
Participants in the intervention arm centres also receive
sessions on goal setting and action planning as part of the
DAFNE week.
Following DAFNE course delivery patients are invited
back as a group for a 6 week return visit with the educators
(nurse and dietitian) who delivered their original course.
This was considered an essential component of the basic
DAFNE course and was not removed from either arm of
the study. After this 6 week return visit participants in the
usual care arm of the study are offered return visits to the
diabetes clinic at 6, 12 and 18 months post DAFNE train-
ing. This reflects usual care in Irish DAFNE centres prior to
the study. The protocol does not stipulate what issues are
covered in these visits. The only stipulation is that partici-
pants should not be seen in a group setting. It is recog-
nised that attempts are likely to be made to have patients
in this arm of the study seen by the doctor, nurse and/or
dietitian involved in their original DAFNE training. How-
ever, patients may also be seen by diabetes team members
not trained in DAFNE.
Participants in the intervention arm of the study are also
seen at 6, 12 and 18 months. The 6 and 12 month visits
are organised as group education sessions and build onTrials 2009, 10:88 http://www.trialsjournal.com/content/10/1/88
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the concepts of goal setting and action planning intro-
duced during the original DAFNE course. A follow-up cur-
riculum was developed to guide DAFNE educators
involved in delivering these sessions and specific training
in the delivery of this curriculum was given to all interven-
tion arm DAFNE educators. Groups are encouraged to
determine their own priorities and select from a range of
DAFNE self-management skills review topics designed
specifically for these follow-up sessions. The role of the
DAFNE educator is to achieve a blend of a patient-centred
and curriculum-centred approach to the session. Follow-
up curriculum topics include HbA1c and targets, diary
keeping and self-monitoring, principles of dose adjust-
ment, carbohydrate calculation, hypoglycaemic manage-
ment, exercise and physical activity, alcohol and sick day
rules. An example of a typical timetable for a group fol-
low-up session is outlined in Table 1. Where DAFNE grad-
uates are unwilling or unable to participate in a follow-up
session with their original group they are offered a follow-
up session with a different DAFNE group from that centre.
Every effort is made to avoid delivering follow-up on a
one-to-one basis in this arm of the study. In keeping with
an emphasis on quality assurance an external peer review
of the delivery of one 6 month follow-up session in each
of the 3 intervention arm centres will be undertaken dur-
ing the study.
Outcomes and Measurement
The primary outcome (on which sample size calculations
are based) is the change in HbA1c between baseline and
the 18 month follow-up visit. Patient-reported rates of
severe hypoglycaemia (defined as a hypoglycaemic epi-
sode requiring the assistance of another person for treat-
ment) will be reported as a secondary outcome along with
change in weight and in psychosocial measures of wellbe-
ing and quality of life.
Table 2 shows the measurement plan for the study.
Because of the potential for inter-laboratory variation in
the method and reporting of HbA1c results this outcome
variable was assayed centrally. Blood was sent to the Royal
Victoria Hospital in Belfast which has a track record of co-
ordinating laboratory measurements for large scale stud-
ies. The method used was a DCCT-aligned HPLC assay
(ADAMS-A1c HA-8160). Lipid levels were measured in the
local laboratory in each hospital. License agreements were
obtained for all questionnaires used in the study. The Dia-
betes-Specific Quality of Life Scale (DSQOLS) was orig-
inally developed in Germany [20] and is a quality of life
measure specific for people with type 1 diabetes. It con-
sists of 10 goal or preference items that are weighted to 10
satisfaction items resulting in a preference-weighted treat-
ment satisfaction score. A further 57 items form 8
domains and are rated on a 6-point Likert scale with a
total score reflecting quality of life. The domains are social
relations, leisure time flexibility, physical complaints,
worries about the future, diet restrictions, daily hassles,
fear of hypoglycaemia and daily burdens & restrictions.
For use in the Irish DAFNE Study the scale was altered
slightly from the original to reflect linguistic differences
and more culturally appropriate scale-items. These slight
modifications did not alter the psychometric properties of
the instrument [21]. The Problem Areas in Diabetes
(PAID) measure is a 20 item questionnaire that uses a Lik-
ert-scale to assess an individual's diabetes-related distress
[22]. The Hospital Anxiety and Depression Scale
(HADS) is a dual instrument that uses 7 items along a Lik-
ert-scale to measure both anxiety and depression [23]. It is
a suitable self-rating scale for anxiety and depression in
patients with both somatic and diagnosed mental health
issues with good reliability and responsiveness [24].
The Irish DAFNE Study also includes a qualitative sub-
study and a health economic analysis. The qualitative
research involves in-depth interviews of a sub-set of par-
ticipants at 6 weeks, 6 months and 12 months after deliv-
ery of the DAFNE course. The aim of this work is to
explore participants' attitudes towards DAFNE and the
different methods of follow-up being evaluated in the
main study. The health economic analysis will identify,
measure, value and compare the costs and outcomes of
the 2 different methods of follow-up of DAFNE graduates
Table 1: Typical timetable used during the intervention follow-up sessions
09:30 Welcome
09:40 HbA1c results, review of blood sugar and targets
10:10 Quiz to identify 3 areas the group would like to focus on (patient-centred approach)
10:20 Curriculum used to guide group-led discussion of identified topics
12:10 Goal setting and action planning
12:30 CloseTrials 2009, 10:88 http://www.trialsjournal.com/content/10/1/88
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and examine both of these relative to usual care. A health
economic questionnaire has been developed specifically
for the study and this is administered at baseline and at 6,
12 and 18 months following DAFNE training.
Statistical Considerations
Sample Size
We used a sample size calculator designed for cluster ran-
domised trials [25]. We based the sample size calculation
on an anticipated HbA1c difference between the 2 arms of
the study of 0.5 percent from month 6 onwards. This
came from the observation in the UK study that DAFNE
training led to a 1.0 percent drop in HbA1c at 6 months
but reverted to 0.5 percent by 12 months [9]. Our study
hypothesis is that group follow-up will be able to main-
tain the benefit out to 18 months. Unlike the UK DAFNE
Study patients were not excluded with baseline HbA1c
below 7.5 percent. Based on a standard deviation of
HbA1c of 1.2 and an intra-class correlation co-efficient of
0.05 we estimated that 450 patients would be required to
detect a 0.5 percent difference with 90 percent power.
Planned Analyses
Initially, descriptive analysis will be conducted to fully
profile both the study centres (number of educators and
doctors, years since initial training and size of DAFNE
waiting list) and the participants (age, gender, years since
diagnosis, baseline HbA1c, weight, lipid levels and socio-
economic status). The main analysis, for the entire cohort,
will be an intention-to-treat analysis and will compare dif-
ferences between HbA1c at baseline and at 18 months in
the 2 treatment arms, adjusting for age, gender, study cen-
tre and years since diagnosis. Changes in the rate of severe
hypoglycaemia will also be examined.
In addition to this intention-to-treat analysis we will also
undertake a "per protocol" analysis on those individuals
who attended all of the educational sessions in the inter-
vention arm.
Sensitivity analyses will explore whether adherence to the
intervention influences the effect of the intervention on
primary outcome.
Sub-group analyses
For those individuals with HbA1c above and below 7.5
percent at baseline a separate intention-to-treat analysis
will be conducted to compare differences between HbA1c
at baseline and at 18 months in the 2 treatment arms.
Changes in the rate of severe hypoglycaemia will also be
examined for those with baseline HbA1c above and below
7.5 percent at baseline. The rationale for this approach is
that "benefit" from DAFNE training for individuals with
low HbA1c may amount to a reduction in the frequency of
severe hypoglycaemia.
Psychosocial analyses
With regard to the psychosocial measures, suitable
numerical and graphical summaries (e.g. box plots, scat-
terplots and case profile plots) will be presented to sum-
marise the within-subject (i.e. time) and between-subject
(i.e. treatment group) factors.
Several analyses will be performed to compare the change
in the psychosocial response variables across time and
between groups. These will include linear mixed models
initially, using baseline as a covariate and subsequently
where the response variables will be expressed as changes
from baseline. Different covariance structures will be
compared in order to best model the correlation structure
within subject.
An intention to treat analysis will be performed to com-
pare the estimated effect of the psychosocial response var-
iables when imputing values for all missing data to the
results obtained when analysing the data while ignoring
missing data.
Table 2: Data collections and follow-up intervals
Baseline 6 month 12 month 18 month
Weight xx x x
Central HbA1c xx x x
Lipid panel xx x x
QOL measures (DSQOLS, EQ-5D, PAID, HADS) xx x x
Rate of severe hypoglycaemia xx x x
DSQOLS - Diabetes-Specific Quality of Life Scale; PAID - Problem Areas in Diabetes; HADS - Hospital Anxiety and Depression ScaleTrials 2009, 10:88 http://www.trialsjournal.com/content/10/1/88
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Multiple imputations [26,27] will be performed using a
Predictive Model Based Method where each missing value
is replaced by 5 imputed values. The imputations will be
generated via randomly drawn regression model parame-
ters from the Bayesian posterior distribution based on the
cases for which the imputation variable is observed.
An estimate of the difference in the mean response, for
each of the psychosocial response variables of interest,
when comparing those on the intervention to the con-
trols, will be provided by pooling the results of each 'com-
plete' model (i.e. with imputed values) using the Barnard-
Rubin adjustment method [28]. The estimated coeffi-
cients, standard errors and p-values for the intervention to
control comparison from the original and complete anal-
yses will be reported for each of the psychosocial response
variables in addition to the fraction of information about
the coefficients missing due to non-response/non-attend-
ance.
Trial Governance
The co-ordinating centre for the study is in the Diabetes
Centre in University Hospital Galway. The Principal
Investigator and the Project Manager are based here. Each
participating centre has a local Principal Investigator and
a lead DAFNE Educator. As well as reporting to the Project
Manager on matters relating to the running of the study
each DAFNE centre also has a reporting arrangement with
the Central DAFNE Co-ordinating centre in Northumbria
NHS Trust in North Tyneside, UK. Central DAFNE main-
tains the DAFNE database, an internet-based, password-
protected database used to store demographic, clinical
and laboratory data on DAFNE graduates throughout the
UK and Ireland. Irish centres enter data onto the DAFNE
database. The Project Manager is able to access data from
Irish centres and undertakes quality assurance of these
data. Requests are made to Central DAFNE for ano-
nymised data downloads to enable quality assurance, data
cleaning and statistical analyses to be undertaken.
A Steering Group advises on any issues that arise relating
to the smooth running of the study. In March 2009 the
funding agency (the Health Research Board) undertook a
rigorous mid-term review of the study. This mid-term
review panel included international experts in diabetes
education research, health services research and clinical
trial methodology. The Steering Group responded to a
number of issues raised by the panel and received sign-off
and a guarantee of ongoing funding to study completion
in August 2010.
Discussion
Diabetes education to support self-management is widely
accepted as an integral component of good diabetes care.
Despite this, it is only recently that attention has been
paid in the UK to what constitutes effective diabetes edu-
cation [12,29]. The term structured education has been
introduced to define programmes of diabetes education
that have certain key elements including a curriculum,
trained educators, quality assurance of the delivery of the
programme and audit of outcomes of the education. Sys-
tematic reviews of diabetes education studies have dem-
onstrated a need for better definition of the intervention
and for longer term follow-up or "booster" education
after the initial session [30,31]. The American Diabetes
Association publishes and regularly updates a set of
Standards for Diabetes Self-Management Education [32].
In its January 2009 update the Taskforce on Diabetes Self-
Management Education (DSME) included as one of its
guiding principles the statement that "ongoing support is
critical to sustain progress made by participants during the
DSME program". A recent framework document from
Australia has outlined in a very comprehensive manner
the outcomes that would be expected to be impacted by
diabetes education [33,34]. The authors point out that
those outcomes that are most likely to be impacted upon
by education (knowledge, understanding, self-determina-
tion, psychological adjustment) are difficult to measure
while those clinical outcomes that are easier to measure
are less likely to be directly impacted upon by education.
Given all of these difficulties and a lack of a clear consen-
sus on diabetes education in Ireland, a group of Irish dia-
betes centres has received training and begun delivering a
high quality structured education programme, DAFNE.
The Irish DAFNE study, described in detail in this report,
will evaluate 2 different approaches to supporting DAFNE
graduates in implementing and maintaining good self-
management skills in the 18 months after their initial dia-
betes education. The results of this study should inform
future policy on diabetes education in Ireland. The results
will also inform the important scientific question of how
best to provide diabetes self-management support. The
qualitative and health economic research being under-
taken within the Irish DAFNE Study will give a more in-
depth perspective on the impact of this approach at the
level of the individual patient and at the level of society.
The design of the Irish DAFNE Study presented several
challenges to the study steering group. Although guided
by the CONSORT statement on the conduct and reporting
of high quality randomised controlled trials [18], it
became clear that this was not a straightforward ran-
domised controlled trial. The Irish DAFNE Study is evalu-
ating a non-pharmacological treatment intervention
using a cluster randomised design and has several features
of a pragmatic trial. Therefore, 3 of the extensions of the
CONSORT statement are relevant to our study and its
description [35].Trials 2009, 10:88 http://www.trialsjournal.com/content/10/1/88
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A number of design features help with the study's internal
validity (i.e., they minimise bias). These include the uni-
form approach to DAFNE training across centres and the
incorporation of peer review and quality assurance into
the delivery of the programme. The central measurement
of HbA1c, one of the main study outcomes, is also a
strength of the design. In terms of external validity (or
generalisability) the study also has strengths including the
recruitment of participants from existing waiting lists in
each centre, the use of broad inclusion criteria for poten-
tial participants and the delivery of the intervention by
diabetes clinic personnel. A potential weakness (in terms
of generalisability) is the fact that the results could be seen
as relevant only to centres delivering structured group
education. However, including DAFNE and other similar
programmes there are now in the region of 150 Diabetes
Centres across the UK and Ireland involved in this type of
activity.
Most importantly perhaps, the results of the Irish DAFNE
Study will be relevant to individuals living with Type 1
diabetes. At a time when more and more diabetes studies
are funded by pharmaceutical companies with the inten-
tion of getting a new product to market or identifying a
new indication for an existing drug, it is important not to
forget about interventions and outcomes that are impor-
tant to patients. A recent review of ongoing diabetes stud-
ies (identified through clinical trial registries) found that
only 18 percent included patient important outcomes as
their primary outcome [36]. When primary or secondary
outcomes were examined the number including patient-
important outcomes increased to 46 percent.
It is not easy to secure funding for large studies of non-
pharmacological interventions such as a diabetes educa-
tion programme. Although these studies are beginning to
appear in the Type 2 diabetes literature [16,17] the Irish
DAFNE Study will be one of the largest in the area of Type
1 diabetes and should inform the design and reporting of
future studies.
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